Unexpected synergy between two cancer-linked proteins offers hope for personalised cancer therapy
A team of scientists from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. Having the means to identify ...
Aug 6, 2013
0
0